A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Breast Cancer After Adjuvant Therapy
Clinical trial NCT01152398 · COMPLETED
Trial details
- NCT number
- NCT01152398
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2012-09-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.